Literature DB >> 18846241

Group comparisons: imaging the aging brain.

Gregory R Samanez-Larkin1, Mark D'Esposito.   

Abstract

With the recent growth of functional magnetic resonance imaging (fMRI), scientists across a range of disciplines are comparing neural activity between groups of interest, such as healthy controls and clinical patients, children and young adults and younger and older adults. In this edition of Tools of the Trade, we will discuss why great caution must be taken when making group comparisons in studies using fMRI. Although many methodological contributions have been made in recent years, the suggestions for overcoming common issues are too often overlooked. This review focuses primarily on neuroimaging studies of healthy aging, but many of the issues raised apply to other group designs as well.

Entities:  

Keywords:  ROI; aging; functional magnetic resonance imaging; group studies; hemodynamics; spatial normalization

Mesh:

Year:  2008        PMID: 18846241      PMCID: PMC2563421          DOI: 10.1093/scan/nsn029

Source DB:  PubMed          Journal:  Soc Cogn Affect Neurosci        ISSN: 1749-5016            Impact factor:   3.436


  38 in total

1.  The effects of aging upon the hemodynamic response measured by functional MRI.

Authors:  S A Huettel; J D Singerman; G McCarthy
Journal:  Neuroimage       Date:  2001-01       Impact factor: 6.556

2.  New visions of the aging mind and brain.

Authors:  Patricia Reuter-Lorenz
Journal:  Trends Cogn Sci       Date:  2002-09-01       Impact factor: 20.229

Review 3.  Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging.

Authors:  Mark D'Esposito; Leon Y Deouell; Adam Gazzaley
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

4.  Comparison of spatial normalization procedures and their impact on functional maps.

Authors:  Fabrice Crivello; Thorsten Schormann; Nathalie Tzourio-Mazoyer; Per E Roland; Karl Zilles; Bernard M Mazoyer
Journal:  Hum Brain Mapp       Date:  2002-08       Impact factor: 5.038

5.  Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences.

Authors:  Eric R Cohen; Egill Rostrup; Karam Sidaros; Torben E Lund; Olaf B Paulson; Kamil Ugurbil; Seong-Gi Kim
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

6.  Prefrontal and striatal activation in elderly subjects during concurrent implicit and explicit sequence learning.

Authors:  Howard J Aizenstein; Meryl A Butters; Kristi A Clark; Jennifer L Figurski; V Andrew Stenger; Robert D Nebes; Charles F Reynolds; Cameron S Carter
Journal:  Neurobiol Aging       Date:  2005-06-01       Impact factor: 4.673

Review 7.  Cognitive neuroscience of aging.

Authors:  Cheryl L Grady
Journal:  Ann N Y Acad Sci       Date:  2008-03       Impact factor: 5.691

8.  Individual differences in insular sensitivity during loss anticipation predict avoidance learning.

Authors:  Gregory R Samanez-Larkin; Nick G Hollon; Laura L Carstensen; Brian Knutson
Journal:  Psychol Sci       Date:  2008-04

9.  The variability of human, BOLD hemodynamic responses.

Authors:  G K Aguirre; E Zarahn; M D'esposito
Journal:  Neuroimage       Date:  1998-11       Impact factor: 6.556

10.  Variable precision registration via wavelets: optimal spatial scales for inter-subject registration of functional MRI.

Authors:  J Suckling; C Long; C Triantafyllou; M Brammer; E Bullmore
Journal:  Neuroimage       Date:  2006-01-20       Impact factor: 6.556

View more
  39 in total

Review 1.  Considerations for imaging the adolescent brain.

Authors:  Adriana Galván; Linda Van Leijenhorst; Kristine M McGlennen
Journal:  Dev Cogn Neurosci       Date:  2012-02-27       Impact factor: 6.464

2.  Neural and vascular variability and the fMRI-BOLD response in normal aging.

Authors:  Sridhar S Kannurpatti; Michael A Motes; Bart Rypma; Bharat B Biswal
Journal:  Magn Reson Imaging       Date:  2010-02-01       Impact factor: 2.546

3.  Expected value information improves financial risk taking across the adult life span.

Authors:  Gregory R Samanez-Larkin; Anthony D Wagner; Brian Knutson
Journal:  Soc Cogn Affect Neurosci       Date:  2010-05-25       Impact factor: 3.436

Review 4.  Interpreting developmental changes in neuroimaging signals.

Authors:  Russell A Poldrack
Journal:  Hum Brain Mapp       Date:  2010-06       Impact factor: 5.038

5.  Differential regional decline in dopamine receptor availability across adulthood: Linear and nonlinear effects of age.

Authors:  Kendra L Seaman; Christopher T Smith; Eric J Juarez; Linh C Dang; Jaime J Castrellon; Leah L Burgess; M Danica San Juan; Paul M Kundzicz; Ronald L Cowan; David H Zald; Gregory R Samanez-Larkin
Journal:  Hum Brain Mapp       Date:  2019-04-01       Impact factor: 5.038

Review 6.  Beyond BOLD: optimizing functional imaging in stroke populations.

Authors:  Michele Veldsman; Toby Cumming; Amy Brodtmann
Journal:  Hum Brain Mapp       Date:  2014-12-02       Impact factor: 5.038

7.  Individual differences in the neural signature of subjective value among older adults.

Authors:  Kameko Halfmann; William Hedgcock; Joseph Kable; Natalie L Denburg
Journal:  Soc Cogn Affect Neurosci       Date:  2015-06-17       Impact factor: 3.436

8.  Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis.

Authors:  Teresa M Karrer; Anika K Josef; Rui Mata; Evan D Morris; Gregory R Samanez-Larkin
Journal:  Neurobiol Aging       Date:  2017-05-12       Impact factor: 4.673

9.  Differential patterns of nucleus accumbens activation during anticipation of monetary and social reward in young and older adults.

Authors:  Lena Rademacher; Aallaa Salama; Gerhard Gründer; Katja N Spreckelmeyer
Journal:  Soc Cogn Affect Neurosci       Date:  2013-04-01       Impact factor: 3.436

10.  Lower cognitive reserve in the aging human immunodeficiency virus-infected brain.

Authors:  Linda Chang; John L Holt; Renat Yakupov; Caroline S Jiang; Thomas Ernst
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.